Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 980,942 | 1,499,942 | +519,000 | $24.02M | $39.00M | 7.82% | +$14.98M |
| Boston Scientific Corporation(BSX) | 336,000 | 321,800 | -14,200 | $33.90M | $34.56M | 6.93% | +$668.9K |
| Natera, Inc.(NTRA) | 119,200 | 199,300 | +80,100 | $16.86M | $33.67M | 6.75% | +$16.81M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,720,902 | 1,742,902 | +22,000 | $31.22M | $32.47M | 6.51% | +$1.25M |
| Endeavour Silver Corp.(EXK) | 353,000 | 355,000 | +2,000 | $15.28M | $18.86M | 3.78% | +$3.58M |
| Tenet Healthcare Corporation(THC) | 72,000 | 106,000 | +34,000 | $9.68M | $18.66M | 3.74% | +$8.97M |
| DexCom, Inc.(DXCM) | 180,000 | 210,500 | +30,500 | $12.29M | $18.37M | 3.68% | +$6.08M |
| Danaher Corporation(DHR) | 44,500 | 89,700 | +45,200 | $9.12M | $17.72M | 3.55% | +$8.60M |
| Hinge Health, Inc.CL A(HNGE) | 0 | 322,344 | +322,344 | $0 | $16.68M | 3.34% | +$16.68M |
| Intuitive Surgical, Inc.(ISRG) | 0 | 27,100 | +27,100 | $0 | $14.73M | 2.95% | +$14.73M |
| Genmab A/SADS(GMAB) | 0 | 650,000 | +650,000 | $0 | $13.43M | 2.69% | +$13.43M |
| Repligen Corporation(RGEN) | 0 | 106,500 | +106,500 | $0 | $13.25M | 2.66% | +$13.25M |
| Thermo Fisher Scientific Inc.(TMO) | 15,500 | 29,600 | +14,100 | $7.71M | $12.00M | 2.41% | +$4.29M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 481,000 | 689,500 | +208,500 | $7.39M | $11.56M | 2.32% | +$4.16M |
| Jade Biosciences Inc | 0 | 1,127,186 | +1,127,186 | $0 | $11.26M | 2.26% | +$11.26M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 800,000 | 1,064,500 | +264,500 | $5.02M | $10.21M | 2.05% | +$5.19M |
| UnitedHealth Group Incorporated(UNH) | 50,500 | 32,000 | -18,500 | $26.45M | $9.98M | 2.00% | -$16.47M |
| McKesson Corporation(MCK) | 0 | 13,500 | +13,500 | $0 | $9.89M | 1.98% | +$9.89M |
| Axsome Therapeutics, Inc.(AXSM) | 77,000 | 94,500 | +17,500 | $8.98M | $9.86M | 1.98% | +$884.3K |
| Cencora Inc | 39,300 | 32,800 | -6,500 | $10.93M | $9.84M | 1.97% | -$1.09M |
| HealthEquity, Inc.(HQY) | 78,000 | 92,000 | +14,000 | $6.89M | $9.64M | 1.93% | +$2.75M |
| Encompass Health Corporation(EHC) | 0 | 74,000 | +74,000 | $0 | $9.07M | 1.82% | +$9.07M |
| Revolution Medicines, Inc.(RVMD) | 213,000 | 228,600 | +15,600 | $7.53M | $8.41M | 1.69% | +$878.5K |
| Akero Therapeutics Inc | 57,000 | 134,000 | +77,000 | $2.31M | $7.15M | 1.43% | +$4.84M |
| Omada Health, Inc.(OMDA) | 0 | 390,600 | +390,600 | $0 | $7.15M | 1.43% | +$7.15M |
| Beam Therapeutics Inc.(BEAM) | 709,517 | 409,400 | -300,117 | $13.86M | $6.96M | 1.40% | -$6.89M |
| Humana Inc.(HUM) | 81,000 | 27,600 | -53,400 | $21.43M | $6.75M | 1.35% | -$14.68M |
| Perspective Therapeutics, Inc.(CATX) | 2,197,270 | 1,858,596 | -338,674 | $4.68M | $6.39M | 1.28% | +$1.71M |
| Organon & Co.(OGN) | 535,000 | 640,000 | +105,000 | $7.97M | $6.20M | 1.24% | -$1.77M |
| BridgeBio Pharma, Inc.(BBIO) | 75,000 | 140,000 | +65,000 | $2.59M | $6.05M | 1.21% | +$3.45M |
| Insmed Incorporated(INSM) | 107,000 | 59,000 | -48,000 | $8.16M | $5.94M | 1.19% | -$2.23M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 19,000 | +19,000 | $0 | $5.75M | 1.15% | +$5.75M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 322,100 | 154,000 | -168,100 | $11.66M | $5.60M | 1.12% | -$6.06M |
| Context Therapeutics Inc.(CNTX) | 7,477,200 | 7,477,255 | +55 | $4.58M | $4.90M | 0.98% | +$323.1K |
| Oruka Therapeutics, Inc.(ORKA) | 352,124 | 352,124 | 0 | $3.61M | $3.95M | 0.79% | +$334.5K |
| Immunic, Inc.(IMUX) | 4,454,408 | 5,615,811 | +1,161,403 | $4.86M | $3.92M | 0.79% | -$938.3K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 268,000 | +268,000 | $0 | $3.76M | 0.75% | +$3.76M |
| Doximity, Inc.CL A(DOCS) | 122,500 | 60,000 | -62,500 | $7.11M | $3.68M | 0.74% | -$3.43M |
| Xenon Pharmaceuticals Inc.(XENE) | 229,000 | 107,891 | -121,109 | $7.68M | $3.38M | 0.68% | -$4.31M |
| Verona Pharma PlcADS | 0 | 33,800 | +33,800 | $0 | $3.20M | 0.64% | +$3.20M |
| uniQure N.V.SHS(QURE) | 336,200 | 207,000 | -129,200 | $3.56M | $2.89M | 0.58% | -$678.1K |
| Apogee Therapeutics Inc | 0 | 65,000 | +65,000 | $0 | $2.82M | 0.57% | +$2.82M |
| Soleno Therapeutics Inc | 32,000 | 32,000 | 0 | $2.29M | $2.68M | 0.54% | +$394.6K |
| Cardinal Health, Inc.(CAH) | 0 | 15,000 | +15,000 | $0 | $2.52M | 0.51% | +$2.52M |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 140,000 | +140,000 | $0 | $2.44M | 0.49% | +$2.44M |
| Kezar Life Sciences Inc COM NEW | 502,600 | 502,600 | 0 | $2.45M | $2.30M | 0.46% | -$150.8K |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 232,000 | +232,000 | $0 | $2.18M | 0.44% | +$2.18M |
| MoonLake ImmunotherapeuticsA ORD(MLTX) | 0 | 39,000 | +39,000 | $0 | $1.84M | 0.37% | +$1.84M |
| Arvinas, Inc.(ARVN) | 413,162 | 243,162 | -170,000 | $2.90M | $1.79M | 0.36% | -$1.11M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 925,000 | 150,000 | -775,000 | $11.36M | $1.40M | 0.28% | -$9.96M |
| SCYNEXIS, Inc.(SCYX) | 1,228,910 | 1,228,910 | 0 | $1.17M | $829.3K | 0.17% | -$340.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 134,566 | 134,566 | 0 | $503.3K | $580.0K | 0.12% | +$76.7K |
| Altimmune, Inc.(ALT) | 0 | 105,000 | +105,000 | $0 | $406.4K | 0.08% | +$406.4K |
| Enliven Therapeutics Inc | 11,300 | 11,300 | 0 | $222.4K | $226.7K | 0.05% | +$4.3K |
| Reviva Pharmaceuticals Holding | 138,000 | 138,000 | 0 | $131.6K | $52.6K | 0.01% | -$79.0K |
| Acadia Pharmaceuticals Inc | 169,000 | 0 | -169,000 | $2.81M | $0 | — | -$2.81M |
| agilon health, inc.(AGL) | 305,100 | 0 | -305,100 | $1.32M | $0 | — | -$1.32M |
| Avantor, Inc.(AVTR) | 453,000 | 0 | -453,000 | $7.34M | $0 | — | -$7.34M |
| Biohaven Ltd.(BHVN) | 145,000 | 0 | -145,000 | $3.49M | $0 | — | -$3.49M |
| Blueprint Medicines Corp | 68,500 | 0 | -68,500 | $6.06M | $0 | — | -$6.06M |
| Bruker Corporation(BRKR) | 115,000 | 0 | -115,000 | $4.80M | $0 | — | -$4.80M |
| Capricor Therapeutics, Inc.(CAPR) | 239,000 | 0 | -239,000 | $2.27M | $0 | — | -$2.27M |
| Centessa Pharmaceuticals PlcADS | 529,000 | 0 | -529,000 | $7.61M | $0 | — | -$7.61M |
| Glaukos Corporation(GKOS) | 134,000 | 0 | -134,000 | $13.19M | $0 | — | -$13.19M |
| Hyperfine, Inc.CL A(HYPR) | 222,174 | 0 | -222,174 | $159.1K | $0 | — | -$159.1K |
| IDEAYA Biosciences, Inc.(IDYA) | 445,000 | 0 | -445,000 | $7.29M | $0 | — | -$7.29M |
| Ionis Pharmaceuticals, Inc.(IONS) | 60,000 | 0 | -60,000 | $1.81M | $0 | — | -$1.81M |
| Janux Therapeutics, Inc.(JANX) | 258,000 | 0 | -258,000 | $6.97M | $0 | — | -$6.97M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 80,000 | 0 | -80,000 | $9.93M | $0 | — | -$9.93M |
| Lexeo Therapeutics, Inc.(LXEO) | 645,000 | 0 | -645,000 | $2.24M | $0 | — | -$2.24M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 40,000 | 0 | -40,000 | $1.80M | $0 | — | -$1.80M |
| Neurocrine Biosciences, Inc.(NBIX) | 85,700 | 0 | -85,700 | $9.48M | $0 | — | -$9.48M |
| Newamsterdam Pharma Company ORDINARY SHARES | 68,000 | 0 | -68,000 | $1.39M | $0 | — | -$1.39M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 25,400 | 0 | -25,400 | $16.11M | $0 | — | -$16.11M |
| REGENXBIO Inc.(RGNX) | 260,000 | 0 | -260,000 | $1.86M | $0 | — | -$1.86M |
| Royalty Pharma plcCL A(RPRX) | 87,000 | 0 | -87,000 | $2.71M | $0 | — | -$2.71M |
| Spdr Ser TrS P BIOTECH ST STR SP BIOT | 94,000 | 0 | -94,000 | $7.62M | $0 | — | -$7.62M |
| United Therapeutics Corporation(UTHR) | 16,800 | 0 | -16,800 | $5.18M | $0 | — | -$5.18M |
| Vaxcyte, Inc.(PCVX) | 23,000 | 0 | -23,000 | $868.5K | $0 | — | -$868.5K |
| Vera Therapeutics, Inc.CL A(VERA) | 91,000 | 0 | -91,000 | $2.19M | $0 | — | -$2.19M |